Close Menu
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram
    BusinessNewsAsia.comBusinessNewsAsia.com
    Subscribe
    • Home
    • Top Stories
    • Business
    • Tech
    • Companies
    • Events
    • Announcements
    BusinessNewsAsia.comBusinessNewsAsia.com
    Home»Daily News»Fullerton Healthcare Redeems US$175m 7.0% Senior Perpetual Capital Securities, Underscoring Resilience Amidst COVID-19 Uncertainty
    Daily News

    Fullerton Healthcare Redeems US$175m 7.0% Senior Perpetual Capital Securities, Underscoring Resilience Amidst COVID-19 Uncertainty

    Marie JonesBy Marie JonesApril 7, 2020No Comments3 Mins Read
    Share
    Facebook Twitter LinkedIn Pinterest Email

    FullertonlogoSINGAPORE, Apr 6, 2020 – (ACN Newswire) – Fullerton Healthcare Corporation Limited (“Fullerton Health”), the leading integrated healthcare platform in the Asia Pacific, announces that it has fully redeemed its US$175 million senior perpetual capital securities today, underscoring its financial resilience and commitment to stakeholders amidst economic uncertainty arising from the COVID-19 pandemic.

    The redemption of the 7.0% senior perpetual capital securities (ISIN Code: XS1589875548) was made on the first call date (6 April 2020), funded by a combination of internal and external resources.

    The proceeds from the perpetual securities had helped Fullerton Health expand geographically, add new capabilities and service offerings, and deepen core markets presence. With operations in nine markets, more than 6,500 staff, over 500 owned facilities and a network of over 12,000 third party providers, Fullerton Health is vertically integrated across a range of services, including managed care and network management, primary care, diagnostics, ancillary and speciality care.

    “We would like to take this opportunity to thank the investors of the perpetual securities for their confidence, trust and strategic input over the last three years. Our ability to combine internal and external resources to redeem the perpetual securities underlines the trust placed in the operational and financial strength of Fullerton Health. We will continue to execute our mission to provide affordable and accessible care for all in the Asia Pacific,” said David Sin, Group President of Fullerton Health.

    While the pandemic has affected all healthcare operators, Fullerton Health has been well prepared with its diversification strategy across markets and its service lines, built and well-executed over the years. It serves to buffer the impact of the COVID-19 situation.

    “Our robust and quick infection control response ensures the safety of our staff and viability for patients to access quality care. Our close operational relations with key clients allow us to customise support efforts to help them care for their employees’ health and well-being during this difficult time,” said Ho Kuen Loon, Group Chief Executive Officer of Fullerton Health.

    About Fullerton Health

    Fullerton Health is a leading integrated health system in the Asia Pacific region. Founded in Singapore in 2010, today the Company serves clients through over 500 healthcare facilities and a large global network of healthcare providers across nine markets in the Asia Pacific. Fullerton Health’s value proposition is the integration of healthcare service offerings with customized management and advisory capabilities, in line with its purpose to deliver affordable and accessible care for all in the Asia Pacific. For more information on Fullerton Health, please visit http://www.fullertonhealth.com/.

    For more information, please contact:
    Isaac Tang
    WeR1 Consultants
    D: +65 6737 4844
    M: +65 9178 0269
    E: fullertonhealth@wer1.net

    Fullerton Health
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
    Previous ArticleGreenbriar Executes Cooperation Agreement with China Machinery Engineering Corporation to Build the Large Montalva Solar Facility
    Next Article Start-up Express 2020: A Journey to Success for HK Start-ups

    Related Posts

    GIC Discloses Third Change in Shareholding in Ascletis Pharma Inc. -B (01672.HK) This Year: Further Increases Stake by Over 10 Million Shares, Raising Holding from 7.00% to 8.36%

    June 26, 2026

    ICETECH and PARKEE, a CentrePark Group Subsidiary, Sign MOU to Establish Strategic Collaboration Framework for Indonesia’s Smart Parking Market

    June 25, 2026

    Everest Medicines and Hainan Herui have entered into a commercialization collaboration relating to Hainan Herui’s budesonide enteric capsules, further enhancing patient access to the medication

    June 24, 2026
    Add A Comment

    Comments are closed.

    © 2026 BusinessNewsAsia.com
    • About Us
    • Contact Us
    • BusinessNews.ph
    • AsiaPEVC.com
    • DevFiNews.com
    • RenewableEnergy.ph

    Type above and press Enter to search. Press Esc to cancel.